| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |